Sustained delivery of peptides
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
59
NCT05408663
A Phase 1 Study of EXT608 in Healthy Adults
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 21, 2022
Completion: Jun 13, 2023
NCT06988670
A Phase 2 Trial Investigating the Safety, Tolerability and Efficacy of EXT608 in Adults With Hypoparathyroidism
Phase: Phase 2
Start: May 5, 2025
Completion: May 31, 2027
Loading map...